These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9722032

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antithrombin III replacement in animal models of acquired antithrombin III deficiency.
    Emerson TE.
    Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S37-45; discussion S59-64. PubMed ID: 8186355
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Renal diseases, disseminated intravascular coagulation, and antithrombin III.
    Brandt P, Jespersen J.
    Nephron; 1983 Jan; 34(3):203-4. PubMed ID: 6877453
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of DIC with antithrombin III concentrates.
    Sakata Y, Yoshida N, Matsuda M, Aoki N.
    Bibl Haematol; 1983 Jan; (49):307-16. PubMed ID: 6667252
    [Abstract] [Full Text] [Related]

  • 28. [Hemorrhage in the cases with leukemia].
    Sakuragawa N, Kondo S.
    Rinsho Byori; 1984 Sep; 32(9):954-8. PubMed ID: 6084083
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
    Wisecarver JL, Haire WD.
    Thromb Res; 1989 Jun 15; 54(6):709-17. PubMed ID: 2781511
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J, Rasmussen NR, Sidelmann J.
    Acta Chir Scand Suppl; 1982 Jun 15; 509():105-7. PubMed ID: 6962611
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Coagulation inhibitor substitution during sepsis.
    Fourrier F, Jourdain M, Tournois A, Caron C, Goudemand J, Chopin C.
    Intensive Care Med; 1995 Nov 15; 21 Suppl 2():S264-8. PubMed ID: 8636534
    [Abstract] [Full Text] [Related]

  • 35. [Clinical trial of protease inhibitor in the treatment of fulminant hepatitis].
    Yasunaga M, Mori K, Yamashita S, Okita K.
    Nihon Rinsho; 1991 Sep 15; 49(9):2120-4. PubMed ID: 1960877
    [No Abstract] [Full Text] [Related]

  • 36. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
    Takahashi K.
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct 15; 43(5):889-97. PubMed ID: 6940410
    [No Abstract] [Full Text] [Related]

  • 37. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T, Gando S, Saitoh D, Wada H, Di Nisio M, Thachil J.
    Thromb Res; 2016 Sep 15; 145():46-50. PubMed ID: 27479532
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Observations during the treatment with antithrombin-III concentrate of a case of a tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin.
    Jespersen J, Rasmussen NR, Toftgaard C.
    Thromb Res; 1982 Jun 15; 26(6):457-62. PubMed ID: 7112521
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.